Your browser doesn't support javascript.
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry.
Agrawal, Manasi; Brenner, Erica J; Zhang, Xian; Modesto, Irene; Woolcott, John; Ungaro, Ryan C; Colombel, Jean-Frederic; Kappelman, Michael D.
  • Agrawal M; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Brenner EJ; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Zhang X; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Modesto I; Inflammation and Immunology, Global Medical Affairs, Pfizer Inc, New York, New York, USA.
  • Woolcott J; Inflammation and Immunology, Global Medical Affairs, Pfizer Inc, New York, New York, USA.
  • Ungaro RC; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Colombel JF; The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Kappelman MD; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Inflamm Bowel Dis ; 27(4): 585-589, 2021 03 15.
Article in English | MEDLINE | ID: covidwho-978598

Full text: Available Collection: International databases Database: MEDLINE Main subject: Piperidines / Pyrimidines / Inflammatory Bowel Diseases / Protein Kinase Inhibitors / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Inflamm Bowel Dis Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Ibd

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Piperidines / Pyrimidines / Inflammatory Bowel Diseases / Protein Kinase Inhibitors / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Inflamm Bowel Dis Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Ibd